Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
alirocumab
alnylam pharmaceuticals
amgen
biotech
boston blog main
clinical trials
evolocumab
inclisiran
life sciences
national blog main
new york
new york blog main
new york top stories
pcsk9 inhibitors
regeneron pharmaceuticals
rna interference
boston top stories
deals
drugs
evercore isi
fda
heart attack
joseph swartz
medicines co.
national top stories
novartis
pcsk9
sanofi
stroke
svb leerink
the medicines company
umer raffat
What
cholesterol
3
×
drug
medicines
3
×
new
3
×
fda
heart
lowering
medco
wave
acquire
administration
advisory
agreed
alnylam
approval
approving
attacks
based
billion
brings
cardiovascular
cash
company
compound
data
deal
dramatically
evidence
favor
food
greatly
health
help
injectable
lasting
ldl
long
looms
lowers
note
Language
unset
Current search:
cholesterol
×
medicines
×
new
×
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
4 years ago
MedCo Touts New Data for Long-Lasting Heart Drug as Reckoning Looms
@theverge.com
8 years ago
FDA panel recommends approving new drug that dramatically lowers cholesterol